Cargando…
New advances in beta-blocker therapy in heart failure
The use of β-blockers (BB) in heart failure (HF) has been considered a contradiction for many years. Considering HF simply as a state of inadequate systolic function, BB were contraindicated because of their negative effects on myocardial contractility. Nevertheless, evidence collected in the past y...
Autores principales: | Barrese, Vincenzo, Taglialatela, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827547/ https://www.ncbi.nlm.nih.gov/pubmed/24294204 http://dx.doi.org/10.3389/fphys.2013.00323 |
Ejemplares similares
-
Treatment optimization of beta-blockers in chronic heart failure therapy
por: Niriayo, Yirga Legesse, et al.
Publicado: (2020) -
Beta-blocker therapy in elderly patients with renal dysfunction and heart failure
por: Martínez-Milla, Juan, et al.
Publicado: (2021) -
Search for HRV-parameters that detect a sympathetic shift in heart failure patients on β-blocker treatment
por: Zhang, Yanru, et al.
Publicado: (2013) -
Beta-Blockers and Oxidative Stress in Patients with Heart Failure
por: Nakamura, Kazufumi, et al.
Publicado: (2011) -
Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2020)